Loss of miR-6844 alters stemness/self-renewal and cancer hallmark(s) markers through CD44-JAK2-STAT3 signaling axis in breast cancer stem-like cells
dc.contributor.author | Prajapati, Kumari Sunita | |
dc.contributor.author | Kumar, Shashank | |
dc.date.accessioned | 2024-01-16T14:23:27Z | |
dc.date.accessioned | 2024-08-13T10:34:19Z | |
dc.date.available | 2024-01-16T14:23:27Z | |
dc.date.available | 2024-08-13T10:34:19Z | |
dc.date.issued | 2023-07-12T00:00:00 | |
dc.description.abstract | MicroRNAs regulate breast stemness and self-renewal properties in breast cancer cells at the molecular level. Recently we reported the clinical relevance and in vitro expression profile of novel miR-6844 in breast cancer and -derived stem-like cells (mammosphere). In the present study, we first time explore the functional role of loss of miR-6844 in breast cancer cells derived mammosphere. Down expression of miR-6844 significantly decreased cell proliferation in MCF-7 and T47D cells derived mammosphere in a time-dependent manner. MiR-6844 down expression reduced the sphere formation in terms of size and number in test cells. Loss of miR-6844 significantly altered stemness and self-renewal markers (Bmi-1, Nanog, c-Myc, Sox2, and CD44) in mammosphere compared to negative control spheres. Moreover, loss of miR-6844 inhibits the JAK2-STAT3 signaling pathway by decreasing p-JAK2 and p-STAT3 levels in breast cancer cells derived mammosphere. Loss of miR-6844 expression significantly decreased CCND1 and CDK4 mRNA/protein levels and arrested breast cancer stem-like cells in G2/M phase. Reduced expression of miR-6844 increased Bax/Bcl-2 ratio, late apoptotic cell population, and Caspase 9 and 3/7 activity in the mammosphere. Low expression of miR-6844 decreased migratory and invasive cells by altering the expression of Snail, E-cad, and Vimentin at mRNA/protein levels. In conclusion, loss of miR-6844 decreases stemness/self-renewal and other cancer hallmark in breast cancer stem-like cells through CD44-JAK2-STAT3 axis. Thus, downregulation of miR-6844 by therapeutic agents might be a novel strategy to target breast cancer stemness and self-renewal. � 2023 Wiley Periodicals LLC. | en_US |
dc.identifier.doi | 10.1002/jcb.30441 | |
dc.identifier.issn | 7302312 | |
dc.identifier.uri | https://doi.org/10.1002/jcb.30441 | |
dc.identifier.uri | https://kr.cup.edu.in/handle/32116/2937 | |
dc.language.iso | en_US | en_US |
dc.publisher | John Wiley and Sons Inc | en_US |
dc.subject | apoptosis | en_US |
dc.subject | breast cancer stem-like cells | en_US |
dc.subject | cell cycle | en_US |
dc.subject | metastasis/Invasion | en_US |
dc.subject | microRNA | en_US |
dc.title | Loss of miR-6844 alters stemness/self-renewal and cancer hallmark(s) markers through CD44-JAK2-STAT3 signaling axis in breast cancer stem-like cells | en_US |
dc.title.journal | Journal of Cellular Biochemistry | en_US |
dc.type | Article | en_US |
dc.type.accesstype | Closed Access | en_US |